Federal enforcers have opened a consumer protection probe into the American Academy of Pediatrics and the leading professional association focused on transgender health care, adding to the Trump ...
Get the latest on the science of healthy living in our weekly newsletter. Jason Krynicki will never forget how obesity made him a target for vicious bullying from the time he was little. Those ...
WASHINGTON, Jan 31 - Elon Musk's SpaceX wants to launch a constellation of 1 million satellites that will orbit Earth and harness the sun to power AI data centers, according to a filing at the Federal ...
Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...
The Federal Trade Commission said Tuesday it will appeal the November ruling in favor of Meta in its antitrust case against the social media giant. Ticker: Spirit Airlines climbing out of bankruptcy; ...
X is putting its money where its mouth is. The Elon Musk-owned social media platform just pledged it will give $1 million to the user who creates the most popular long-form post using its newly ...
The editorial board is a group of opinion journalists whose views are informed by expertise, research, debate and certain longstanding values. It is separate from the newsroom. President Trump has ...
Long-term GLP-1 use slows medical cost growth, according to findings published Jan. 13 from professional services firm Aon. The firm analyzed 192,000 GLP-1 users from July 2022 to March 2025, ...
The incidence of colorectal cancer among users of GLP-1RAs was approximately 36% lower than that observed among aspirin users. The use of GLP-1 receptor antagonist (GLP-1RA) therapy has led to a ...
For women with obesity, GLP-1 medications like Ozempic and Wegovy may help address the metabolic challenges that often intensify during midlife. The hormonal shifts of perimenopause and menopause can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results